TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Direct and Indirect Laryngoscopy Using C-MAC PM® With Macintosh Blade and D-Blade® in Simulated Difficult Airway
Brief Summary: In the presented study, our aim was to compare intubation conditions regarding the modified Cormack \& Lehane score (CL) between the D-Blade® in indirect laryngoscopy or Macintosh blade in direct and indirect laryngoscopy with C-MAC PM® in a simulated setting of a difficult airway in human subjects.


Options:
A: Arm Label: Direct Laryngoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Direct Laryngoscopy | Arm Label: CMAC; Type: EXPERIMENTAL; Interventions: Procedure: CMAC videolaryngoscope | Intervention Type: PROCEDURE; Name: CMAC videolaryngoscope; Assigned to Arm(s): CMAC | Intervention Type: PROCEDURE; Name: Direct Laryngoscopy; Assigned to Arm(s): Direct Laryngoscopy
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Device: C-MAC videolaryngoscope intubation, Device: Direct laryngoscope intubation | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Device: C-MAC videolaryngoscope intubation, Device: Direct laryngoscope intubation | Intervention Type: DEVICE; Name: C-MAC videolaryngoscope intubation; Assigned to Arm(s): Group A, Group B | Intervention Type: DEVICE; Name: Direct laryngoscope intubation; Assigned to Arm(s): Group A, Group B
C: Arm Label: Truview EVO2®; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Arm Label: Airtraq®; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Arm Label: Direct laryngoscopy; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Intervention Type: OTHER; Name: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes; Assigned to Arm(s): Airtraq®, Direct laryngoscopy, Truview EVO2®
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Macintosh blade, Device: D-Blade, Device: Intubation | Intervention Type: DEVICE; Name: Macintosh blade; Assigned to Arm(s): Intervention | Intervention Type: DEVICE; Name: D-Blade; Assigned to Arm(s): Intervention | Intervention Type: DEVICE; Name: Intubation; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Time-Restricted Feeding Plus Resistance Training in Active Females: Effects on Body Composition, Muscular Performance and Physiological Variables
Brief Summary: The objective of this study is to examine the effects of time-restricted feeding (TRF; consuming all calories within an 8-hour period of time each day) and resistance training, with or without the addition of the dietary supplement HMB, on body composition, muscular performance and physiological outcomes in active females.


Options:
A: Arm Label: Breakfast Rest; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Breakfast | Arm Label: Breakfast Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise, Dietary Supplement: Breakfast | Arm Label: Fasted Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Breakfast Exercise, Fasted Exercise | Intervention Type: DIETARY_SUPPLEMENT; Name: Breakfast; Assigned to Arm(s): Breakfast Exercise, Breakfast Rest
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Alternate Day Fasting Arm; Type: OTHER; Interventions: Behavioral: calorie restriction | Arm Label: Calorie Restriction; Type: OTHER; Interventions: Behavioral: calorie restriction | Intervention Type: BEHAVIORAL; Name: calorie restriction; Assigned to Arm(s): Alternate Day Fasting Arm, Calorie Restriction
C: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: CHARMS | Intervention Type: BEHAVIORAL; Name: CHARMS; Assigned to Arm(s): Lifestyle counseling
D: Arm Label: Normal Diet; Type: PLACEBO_COMPARATOR; Interventions: Other: Resistance Training, Dietary Supplement: Protein Supplementation | Arm Label: Time-Restricted Feeding; Type: EXPERIMENTAL; Interventions: Other: Resistance Training, Dietary Supplement: Protein Supplementation, Behavioral: Time-Restricted Feeding | Arm Label: Time-Restricted Feeding plus HMB; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Beta-hydroxy beta-methylbutyrate, Other: Resistance Training, Dietary Supplement: Protein Supplementation, Behavioral: Time-Restricted Feeding | Intervention Type: DIETARY_SUPPLEMENT; Name: Beta-hydroxy beta-methylbutyrate; Assigned to Arm(s): Time-Restricted Feeding plus HMB | Intervention Type: OTHER; Name: Resistance Training; Assigned to Arm(s): Normal Diet, Time-Restricted Feeding, Time-Restricted Feeding plus HMB | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein Supplementation; Assigned to Arm(s): Normal Diet, Time-Restricted Feeding, Time-Restricted Feeding plus HMB | Intervention Type: BEHAVIORAL; Name: Time-Restricted Feeding; Assigned to Arm(s): Time-Restricted Feeding, Time-Restricted Feeding plus HMB

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Ultrasound-guided Radial Artery Cannulation Using Dynamic Short Axis Versus Conventional Long-axis In-plane View in Cardiac Surgery Patients.
Brief Summary: When performing vascular cannulation such as radial artery cannulation, ultrasonography (US) helps proper positioning of the tip of needle in the vascular lumen, which facilitating cannulation of the catheter and successful pressure monitoring. Conventionally, short-axis out-of-plane (SAX) and long-axis in-plane (LAX) views are commonly used method to image the target vessel during cannulation under US guidance. Dynamic needle tip positioning (DNTP) method is newly introduced by one group of investigators who conducted a related study using vascular phantom model.

In DNTP, SAX is used, and additionally, when the needle tip is imaged in the screen as an echogenic point, the practitioner (a) proximally moves the US probe a bit, and then (b) the needle is advanced until the needle tip reappears in the screen. In this manner, the practitioner repeats (a) and (b) until the needle is inserted 1 cm into the lumen of vessel, and then the catheter is inserted to finish the procedure.

DNTP has not been compared to conventional imaging methods. The aim of this trial is to see the effect of DNTP on success rate of the radial artery cannulation at the first attempt, compared to the conventional LAX.


Options:
A: Arm Label: Palpation group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial arterial cannulation | Arm Label: Ultrasound group; Type: EXPERIMENTAL; Interventions: Procedure: Radial arterial cannulation | Intervention Type: PROCEDURE; Name: Radial arterial cannulation; Assigned to Arm(s): Palpation group, Ultrasound group
B: Arm Label: Dynamic needle tip positioning; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Dynamic needle tip positioning under ultrasound-guidance | Arm Label: Conventional long-axis; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional long-axis view | Intervention Type: PROCEDURE; Name: Dynamic needle tip positioning under ultrasound-guidance; Assigned to Arm(s): Dynamic needle tip positioning | Intervention Type: PROCEDURE; Name: Conventional long-axis view; Assigned to Arm(s): Conventional long-axis
C: Arm Label: Conventional method (CM); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial artery cannulation | Arm Label: Ultrasound guided method (USG); Type: EXPERIMENTAL; Interventions: Procedure: Radial artery cannulation | Intervention Type: PROCEDURE; Name: Radial artery cannulation; Assigned to Arm(s): Conventional method (CM), Ultrasound guided method (USG)
D: Arm Label: CAIG; Type: EXPERIMENTAL; Interventions: Device: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.; Assigned to Arm(s): CAIG

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Double-blind, Community-based Efficacy Trial of Various Doses of Zinc in Micronutrient Powders or Tablets in Young, Bangladeshi Children
Brief Summary: This is a randomized, double-blind, community-based efficacy trial of different doses, forms, and frequencies of zinc supplementation for the prevention of diarrhea and promotion of linear growth among children 9-11 months of age in Dhaka, Bangladesh.


Options:
A: Intervention Type: DRUG; Name: zinc sulphate dietary supplement; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: iron sulphate-folic acid dietary supplement; Assigned to Arm(s): N/A
B: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins | Arm Label: Multivitamins + Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc, Drug: Multivitamins | Arm Label: Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): Multivitamins + Zinc, Zinc | Intervention Type: DRUG; Name: Multivitamins; Assigned to Arm(s): Multivitamins, Multivitamins + Zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Active; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 10 mg zinc oxide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: 10 mg zinc oxide; Assigned to Arm(s): Active | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1. Standard MNP; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Standard MNP | Arm Label: 2. High zinc, low iron MNP; Type: EXPERIMENTAL; Interventions: Dietary Supplement: High zinc, low iron MNP | Arm Label: 3. High zinc, low/no iron; Type: EXPERIMENTAL; Interventions: Dietary Supplement: High zinc, low/no iron on alternating days | Arm Label: 4. Dispersible zinc supplement; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Dispersible zinc supplement | Arm Label: 5. Intermittent zinc supplement; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Intermittent zinc supplement | Arm Label: 6. Placebo powder; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo powder | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard MNP; Assigned to Arm(s): 1. Standard MNP | Intervention Type: DIETARY_SUPPLEMENT; Name: High zinc, low iron MNP; Assigned to Arm(s): 2. High zinc, low iron MNP | Intervention Type: DIETARY_SUPPLEMENT; Name: High zinc, low/no iron on alternating days; Assigned to Arm(s): 3. High zinc, low/no iron | Intervention Type: DIETARY_SUPPLEMENT; Name: Dispersible zinc supplement; Assigned to Arm(s): 4. Dispersible zinc supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Intermittent zinc supplement; Assigned to Arm(s): 5. Intermittent zinc supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo powder; Assigned to Arm(s): 6. Placebo powder

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Restrictive Versus Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur Study
Brief Summary: The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.


Options:
A: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
B: Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Intervention Type: BIOLOGICAL; Name: Administration of Red Cell; Assigned to Arm(s): Liberal, Restrictive
C: Arm Label: Treatment group; Type: EXPERIMENTAL; Interventions: Other: Ultrafiltration of residual blood | Arm Label: Control; Type: NO_INTERVENTION; Interventions: Other: Ultrafiltration of residual blood | Intervention Type: OTHER; Name: Ultrafiltration of residual blood; Assigned to Arm(s): Control, Treatment group
D: Arm Label: Restrictive transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive transfusion strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal transfusion strategy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Restrictive Versus Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur Study
Brief Summary: The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.


Options:
A: Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Intervention Type: BIOLOGICAL; Name: Administration of Red Cell; Assigned to Arm(s): Liberal, Restrictive
B: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Liberal transfusion strategy | Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Behavioral: Restrictive transfusion strategy | Intervention Type: BEHAVIORAL; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal | Intervention Type: BEHAVIORAL; Name: Restrictive transfusion strategy; Assigned to Arm(s): Restrictive
C: Arm Label: Restrictive Transfusion Policy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion policy | Arm Label: Liberal Transfusion Policy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal Transfusion Policy | Intervention Type: OTHER; Name: Restrictive transfusion policy; Assigned to Arm(s): Restrictive Transfusion Policy | Intervention Type: OTHER; Name: Liberal Transfusion Policy; Assigned to Arm(s): Liberal Transfusion Policy
D: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Restrictive Versus Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur Study
Brief Summary: The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.


Options:
A: Arm Label: Red blood cell transfusion; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Red blood cell transfusion
B: Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Intervention Type: BIOLOGICAL; Name: Administration of Red Cell; Assigned to Arm(s): Liberal, Restrictive
C: Arm Label: Standard of care; Type: ACTIVE_COMPARATOR; Interventions: Other: Blood transfusion | Arm Label: Arm B; Type: OTHER; Interventions: Other: Blood transfusion | Intervention Type: OTHER; Name: Blood transfusion; Assigned to Arm(s): Arm B, Standard of care
D: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Restrictive Versus Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur Study
Brief Summary: The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.


Options:
A: Arm Label: Red blood cell transfusion; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Red blood cell transfusion
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: FE; Type: EXPERIMENTAL; Interventions: Drug: Ferric carboxymaltose | Arm Label: EPOFE; Type: EXPERIMENTAL; Interventions: Drug: Ferric carboxymaltose, Drug: Erythropoietin | Intervention Type: DRUG; Name: Ferric carboxymaltose; Assigned to Arm(s): EPOFE, FE | Intervention Type: DRUG; Name: Erythropoietin; Assigned to Arm(s): EPOFE | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Intervention Type: BIOLOGICAL; Name: Administration of Red Cell; Assigned to Arm(s): Liberal, Restrictive
D: Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Intervention Type: PROCEDURE; Name: Blood Transfusion; Assigned to Arm(s): Liberal, Restrictive

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tomographic and Histological Evaluation of Postextraction Sockets Treated With Leucocyte- and Platelet-rich Fibrin: a Randomized Clinical Trial
Brief Summary: The effect of leucocyte- and platelet-rich fibrin (L-PRF) for enhancing the healing after dental extractions is still a matter of debate. The available literature suggests that L-PRF performs positive effect to improve alveolar preservation resulting in less bone resorption on extraction sockets. L-PRF is a second generation of platelet concentrate produced without biochemical blood manipulation. L-PRF is composed by three key parameters: first, the presence of platelets; second, the presence of leucocytes; third, the density and complex organization of the fibrin matrix architecture produced by a natural polymerization process. The theory is that this key parameters acts to produce a faster bone healing.


Options:
A: Arm Label: Combination 50% cortical/50% cancellous FDBA; Type: EXPERIMENTAL; Interventions: Device: 50% cortical/50% cancellous FDBA | Arm Label: 100% cortical FDBA; Type: ACTIVE_COMPARATOR; Interventions: Device: 100% cortical FDBA | Arm Label: 100% cancellous FDBA; Type: ACTIVE_COMPARATOR; Interventions: Device: 100% cancellous FDBA | Intervention Type: DEVICE; Name: 50% cortical/50% cancellous FDBA; Assigned to Arm(s): Combination 50% cortical/50% cancellous FDBA | Intervention Type: DEVICE; Name: 100% cortical FDBA; Assigned to Arm(s): 100% cortical FDBA | Intervention Type: DEVICE; Name: 100% cancellous FDBA; Assigned to Arm(s): 100% cancellous FDBA
B: Arm Label: Ridge preservation; Type: OTHER; Interventions: Procedure: Ridge preservation | Arm Label: No ridge preservation; Type: OTHER; Interventions: Procedure: Ridge preservation | Intervention Type: PROCEDURE; Name: Ridge preservation; Assigned to Arm(s): No ridge preservation, Ridge preservation
C: Arm Label: Test: Porcine Xenograft (Zcore); Type: EXPERIMENTAL; Interventions: Device: Porcine Xenograft (Zcore) | Arm Label: Active Control: Bovine Xenograft (Bio-Oss); Type: ACTIVE_COMPARATOR; Interventions: Device: Bovine Xenograft (Bio-Oss) | Intervention Type: DEVICE; Name: Porcine Xenograft (Zcore); Assigned to Arm(s): Test: Porcine Xenograft (Zcore) | Intervention Type: DEVICE; Name: Bovine Xenograft (Bio-Oss); Assigned to Arm(s): Active Control: Bovine Xenograft (Bio-Oss)
D: Arm Label: L-PRF group; Type: EXPERIMENTAL; Interventions: Procedure: Platelet-rich fibrin | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Platelet-rich fibrin; Assigned to Arm(s): L-PRF group

Answer: D